Tags

Type your tag names separated by a space and hit enter

The Promise and Peril of Antibody Testing for COVID-19.
JAMA. 2020 May 19; 323(19):1881-1883.JAMA

Links

Publisher Full Text
Aggregator Full Text

Authors

Abbasi J
No affiliation info available

MeSH

Antibodies, ViralBetacoronavirusCOVID-19COVID-19 TestingClinical Laboratory TechniquesCommunicable Disease ControlCoronavirus InfectionsFalse Negative ReactionsHumansImmunoglobulin GImmunoglobulin MMass ScreeningPandemicsPneumonia, ViralPoint-of-Care TestingPopulation SurveillanceSARS-CoV-2Sensitivity and Specificity

Pub Type(s)

News

Language

eng

PubMed ID

32301958

Citation

Abbasi, Jennifer. "The Promise and Peril of Antibody Testing for COVID-19." JAMA, vol. 323, no. 19, 2020, pp. 1881-1883.
Abbasi J. The Promise and Peril of Antibody Testing for COVID-19. JAMA. 2020;323(19):1881-1883.
Abbasi, J. (2020). The Promise and Peril of Antibody Testing for COVID-19. JAMA, 323(19), 1881-1883. https://doi.org/10.1001/jama.2020.6170
Abbasi J. The Promise and Peril of Antibody Testing for COVID-19. JAMA. 2020 May 19;323(19):1881-1883. PubMed PMID: 32301958.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Promise and Peril of Antibody Testing for COVID-19. A1 - Abbasi,Jennifer, PY - 2020/4/18/pubmed PY - 2020/9/25/medline PY - 2020/4/18/entrez SP - 1881 EP - 1883 JF - JAMA JO - JAMA VL - 323 IS - 19 SN - 1538-3598 UR - https://www.unboundmedicine.com/medline/citation/32301958/full_citation L2 - https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.6170 DB - PRIME DP - Unbound Medicine ER -